52-Week Performance Chart

Powered by FactSet Research Systems Inc

Recent Company News

More

Powered by FactSet Research Systems Inc.

Data provided by Thomson Reuters

Institutional Ownership

TOP INSTITUTIONAL HOLDERS POSITION
PRIMECAP Management Co. 40,661,485
Wellington Management Co. LLP 34,575,752
Capital Research & Management Co. (International Investors) 31,285,560
TOP MUTUAL FUND HOLDERS POSITION
Vanguard PRIMECAP Fund 25,507,708
Washington Mutual Investors Fund 20,061,543
Invesco QQQ Trust 11,880,391

Data provided by FactSet Research Systems Inc.

DR Details

DR Symbol AZN
CUSIP 046353108
DR Venue New York Stock Exchange
DR ISIN US0463531089
Ratio DR:ORD 2:1
Underlying ISIN GB0009895292
Country United Kingdom
Effective Date Feb 06, 2020
Depositary DB (Sponsored)
Industry Pharma. & Biotech.
AstraZeneca PLC is a science-led biopharmaceutical company. It discovers, develops, and commercializes prescription medicines in oncology, rare diseases, and biopharmaceuticals, including cardiovascular, renal and metabolism, respiratory and immunology and vaccines and immune therapies. Its key marketed oncology products include Tagrisso, Imfinzi, Lynparza, Calquence, Enhertu, Orpathys, Zoladex, Faslodex and others. Its rare diseases products include Soliris, Ultomiris, Strensiq and Kanuma. Its biopharmaceuticals products include Farxiga, Crestor, Breztri and others. Its investigational vaccine candidate IVX-A12, which targets both respiratory syncytial virus and human metapneumovirus.

Data provided by Mergent, Inc.

Fee Type in US Dollar per ADS Deposit Agreement
Cable Fee per Cancellation $17.5000

Monthly Trading Summary

More
Month Month End DR Close Price DR Trading Volume Avg Day DR Trading Volume
Apr.25 71.79 147,512,940 7,024,426
Mar.25 73.50 109,796,138 5,228,388
Feb.25 76.21 124,356,195 6,545,063

Powered by FactSet Research Systems Inc.

This information and data is provided for general informational purposes only.  Certain displayed prices may not reflect direct quotes from any market or exchange, but may instead reflect an approximation of price based on a methodology that includes a calculation that includes the price of underlying securities and foreign exchange rate selected for such purpose. The Bank of New York Mellon and our information suppliers do not warrant or guarantee the accuracy, timeliness or completeness of this information or data. We provide no advice nor recommendation or endorsement with respect to any company or securities. We do not undertake any obligation to update or amend this information or data. Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.
Please refer to Terms of Use

DEPOSITARY RECEIPTS:
NOT FDIC, STATE OR FEDERAL AGENCY INSURED
MAY LOSE VALUE
NO BANK, STATE OR FEDERAL AGENCY GUARANTEE